Salivary anti-cyclic citrullinated peptide as a screening tool for rheumatoid arthritis

OBJECTIVES: This study aims to evaluate the sensitivity and specificity of salivary anti-cyclic citrullinated peptide 3 (anti-CCP3) for the early diagnosis of rheumatoid arthritis. PATIENTS AND METHODS: Between June 2017 and April 2019, a total of 63 patients with rheumatoid arthritis (10 males, 53...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortazavi, Nazanin, Abdolahi, Nafiseh, Saeidi, Mohsen, Ali Vakili, Mohammad, Mohebrad, Pouria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208623/
https://www.ncbi.nlm.nih.gov/pubmed/37235122
http://dx.doi.org/10.46497/ArchRheumatol.2023.9032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208623/
https://www.ncbi.nlm.nih.gov/pubmed/37235122
http://dx.doi.org/10.46497/ArchRheumatol.2023.9032

Ejemplares similares